Lonza
Paul Kim is a seasoned architect with extensive experience in project management within the construction and architectural sectors, currently serving as the Lead Architect, CSA Leader, and Client Representative at Lonza since June 2023. Specializing in the development and execution of building projects, particularly in the pharmaceutical and biotechnology industries, Paul has previously held significant roles at Pharmaplan (TTP Group) as a Senior Architect and CSA Leader, and at Herzog & de Meuron as a project leader. Paul’s expertise encompasses project team leadership, planning and coordination of large-scale construction projects, and the implementation of BIM design. Paul holds a Diplom-Ingenieur degree in Architecture from the Universität der Künste Berlin, obtained in 2012.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.